PANCREAS CANCER

This early-stage study tested a new nanoparticle form of a cancer drug called SNB-101 in 21 patients with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and see how the body processes the drug. Patients received the…

This early-stage study tested a personalized vaccine designed to teach the immune system to attack pancreatic cancer cells. The trial involved 33 patients with pancreatic cancer who had already received chemotherapy. Participants received the vaccine either before or after surger…

This study tested a combination of two oral drugs, vemurafenib and sorafenib, in 10 patients with advanced pancreatic cancer that had a specific genetic change (KRAS mutation) and had stopped responding to standard chemotherapy. The main goal was to see if the drug combo could co…

This small, early-stage study aimed to see if it was safe to add a drug called anakinra to standard chemotherapy for people with advanced pancreatic cancer that had spread. Anakinra is an anti-inflammatory drug approved for rheumatoid arthritis. Researchers wanted to check for si…

This study tested whether combining two drugs, pembrolizumab (an immunotherapy) and azacitidine, could help control advanced pancreatic cancer that had worsened after initial chemotherapy. All 36 participants received the drug combination. The goal was to see if this new approach…

This study tested whether remote monitoring could help patients with advanced pancreatic cancer better tolerate their chemotherapy. Patients used a chest sensor, smart scale, and tablet to track symptoms, weight, and activity from home. The goal was to spot early warning signs an…

This study tested a two-step treatment for advanced pancreatic cancer. First, patients received standard chemotherapy plus experimental drugs designed to make cancer cells more vulnerable. If their disease was controlled after three cycles, they moved to a second phase receiving …

This large, completed study aimed to find out which of two commonly used antibiotics works better at preventing surgical site infections after a major pancreatic surgery called pancreatoduodenectomy. Nearly 1,000 adult patients scheduled for this surgery were randomly assigned to…

This study tested whether doctors could safely take small samples of a patient's pancreatic cancer tumor and grow miniature 3D versions (organoids) in the lab. Researchers then used these mini-tumors to test which chemotherapy drugs worked best against that specific patient's can…

This study tested a digital tool designed to help cancer survivors learn about and decide whether to get genetic testing for hereditary cancer risk. Researchers wanted to see if this smart technology was easy to use and if it encouraged more people to get tested. They compared th…